22 results on '"Billiet, C."'
Search Results
2. Tumeurs de petits stades. La chirurgie a-t-elle encore sa place ?
3. Insight et interventions psychoéducationnelles dans la schizophrénie
4. Résultats de l'exérèse des récidives locorégionales des cancers du rectum
5. OC-0762 Single fraction SBRT vs 3D-CRT for painful bone metastases: a single-blind phase 3 RCT (NCT03831243).
6. OC-0267 Long-term results of an SBRT dose-escalation trial for bone and lymph node metastases (NCT03486431).
7. PO-0882 Outcome and Toxicity of Hypofractionated Image-Guided SABR for Spinal Oligometastases.
8. EP-1237: Heart dose as a risk factor for dyspnea worsening after multimodality treatment for NSCLC and MPM.
9. PO-0688: Patterns of LR for stage III N2 NSCLC patients after chemotherapy and surgery: implications for PORT.
10. 126P: Outcome after post-operative radiotherapy (PORT) in ypN2 or R1/R2 versus no PORT in ypN0 stage III-N2 non-small cell lung cancer after induction chemotherapy and resection.
11. PO-1383 Neoadjuvant versus definitive chemoradiation for esophageal cancer: a retrospective analysis.
12. OC-0270 Metastases-directed SRT and systemic therapy: EORTC-ESTRO OligoCare delphi consensus recommendations.
13. EP-1621 First results of the first cohort of a phase I dose-escalation trial on SABR for oligometastases.
14. EP-1519 PSMA-PET/CT for guidance and response assessment of SABR for prostate cancer oligometastases.
15. Accelerated Adaptation of Ultrahypofractionated Radiation Therapy for Breast Cancer at the Time of the COVID-19 Pandemic.
16. 74P Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity.
17. OC-0135 Predicting patient-reported symptom clusters in lung cancer patients: a machine learning approach.
18. PO-0694: Lung toxicity modelling in thoracic post-operative RT for NSCLC and pleural mesothelioma.
19. 144 (PB-057) Poster - Ultrahypofractionated radiation therapy for breast cancer: two-year normal tissue effects.
20. PO-1871 Prospective study on the feasibility of single-fraction SABR for bone and lymph node metastases.
21. OC-0452: Mature results of a phase I dose-escalation trial of SBRT for bone and lymph node oligometastases.
22. PO-0765 Oncological and cosmetic outcome after IOERT as a boost in a large cohort of breast cancer patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.